QIAGEN N.V.
QGEN
$42.07
-$0.99-2.30%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.98B | 1.97B | 1.94B | 1.94B | 1.97B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.98B | 1.97B | 1.94B | 1.94B | 1.97B |
| Cost of Revenue | 940.43M | 946.36M | 936.99M | 657.25M | 667.43M |
| Gross Profit | 1.04B | 1.02B | 1.00B | 1.28B | 1.30B |
| SG&A Expenses | 564.36M | 568.60M | 568.06M | 570.28M | 579.17M |
| Depreciation & Amortization | 68.14M | 71.55M | 74.24M | 75.08M | 74.96M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.77B | 1.78B | 1.77B | 1.50B | 1.52B |
| Operating Income | 211.79M | 188.81M | 166.58M | 440.97M | 445.25M |
| Income Before Tax | 121.15M | 114.17M | 97.55M | 423.31M | 429.81M |
| Income Tax Expenses | 37.56M | 21.24M | 24.85M | 86.37M | 88.51M |
| Earnings from Continuing Operations | 83.59 | 92.93 | 72.70 | 336.94 | 341.30 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 83.59M | 92.93M | 72.70M | 336.94M | 341.30M |
| EBIT | 211.79M | 188.81M | 166.58M | 440.97M | 445.25M |
| EBITDA | 402.06M | 386.39M | 364.74M | 636.88M | 638.88M |
| EPS Basic | 0.38 | 0.42 | 0.33 | 1.56 | 1.58 |
| Normalized Basic EPS | 0.68 | 0.62 | 0.56 | 1.33 | 1.36 |
| EPS Diluted | 0.37 | 0.41 | 0.32 | 1.55 | 1.57 |
| Normalized Diluted EPS | 0.67 | 0.62 | 0.55 | 1.32 | 1.35 |
| Average Basic Shares Outstanding | 867.59M | 867.18M | 866.31M | 865.65M | 862.95M |
| Average Diluted Shares Outstanding | 871.93M | 871.52M | 871.19M | 872.75M | 869.95M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |